Investigating angiotensin II concentration in modulating Plasmodium falciparum infection and angiotensin receptor activation
Authors:
Open Access
- 10 August 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Parasitology
- Vol. 5, 1852476
Abstract
Introduction: Angiotensin II (Ang II) has been proposed to protect from severe malaria by killing the parasite and maintaining the blood-brain barrier integrity by acting through type 1 (AT 1 R) and type 2 (AT 2 R) receptors. However, this protection from severe malaria is counterproductive in adulthood as the elevated plasma Ang II puts the individual at risk for developing hypertension. Various natural and synthetic peptides of Ang II have been explored to check its antiplasmodial actions despite Ang II being a significant vasopressor via its actions through AT 1 R. Therefore, to be able to explore Ang II as a potential antiplasmodial agent, it is important to demonstrate its IC 50 against P. falciparum in vitro and its minimum effective concentration required for activation of AT 1 R. It is desirable that IC 50 of Ang II against P. falciparum remains below the threshold for AT 1 R activation and hence to verify this, the current study was planned as there are no previously published reports for determining the threshold Ang II concentration for AT 1 R activation. Methods: For invasion inhibition assay, Pf-infected RBCs (schizonts) were incubated with four different concentrations of Ang II for 16 hours. The activation of AT 1 R and AT 2 R in the presence of Ang II (from 10 –9 M to 10 –7 M) was tested by calcium and cGMP signaling assays, respectively using the human brain microvascular endothelial cell line as an in vitro model. Results: Effective Ang II concentration among all tested concentrations was found to be 10 –6 M against Plasmodium falciparum invasion. Statistically non-significant and negligible responses in AT 1 R and AT 2 R activation were observed below the desired Ang II concentration of 10 –6 M. Discussion: The results indicate that the IC 50 of Ang II against P. falciparum is below the threshold for AT 1 R activation. However, the minimum effective Ang II concentration required for AT 1 R activation remains unanswered which demands further improvement in experimental designs.Keywords
This publication has 40 references indexed in Scilit:
- Trypan Blue Exclusion Test of Cell ViabilityCurrent Protocols in Immunology, 2015
- Effects of the angiotensin II Ala-scan analogs in erythrocytic cycle of Plasmodium falciparum (in vitro) and Plasmodium gallinaceum (ex vivo)Experimental Parasitology, 2015
- Angiotensin II restricted analogs with biological activity in the erythrocytic cycle of Plasmodium falciparumJournal of Peptide Science, 2014
- AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal functionPflügers Archiv - European Journal of Physiology, 2012
- Gene polymorphisms in angiotensin I converting enzyme (ACE I/D) and angiotensin II converting enzyme (ACE2 C→T) protect against cerebral malaria in Indian adultsInfection, Genetics and Evolution, 2010
- Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture researchCytotechnology, 2008
- Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosisBiochemical and Biophysical Research Communications, 2006
- Signal Transduction from the Angiotensin II AT2 ReceptorTrends in Endocrinology & Metabolism, 2000
- Angiotensin II-induced calcium signalling in neurons and astrocytes of rat circumventricular organsNeuroscience, 1998
- Plasmodium falciparum: Continuous cultivation of erythrocyte stages in plasma-free culture mediumExperimental Parasitology, 1984